These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1210 related articles for article (PubMed ID: 29307505)

  • 21. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabidiol modulation of antinociceptive tolerance to Δ
    Greene NZ; Wiley JL; Yu Z; Clowers BH; Craft RM
    Psychopharmacology (Berl); 2018 Nov; 235(11):3289-3302. PubMed ID: 30238130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood.
    Manning B; Hayley AC; Catchlove S; Stough C; Downey LA
    Eur Neuropsychopharmacol; 2024 May; 82():35-43. PubMed ID: 38490083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of cannabidiol (CBD) on Δ⁹-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats.
    Wakeford AGP; Wetzell BB; Pomfrey RL; Clasen MM; Taylor WW; Hempel BJ; Riley AL
    Exp Clin Psychopharmacol; 2017 Aug; 25(4):242-248. PubMed ID: 28682102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
    Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
    Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical Marijuana: Just the Beginning of a Long, Strange Trip?
    Ciccone CD
    Phys Ther; 2017 Feb; 97(2):239-248. PubMed ID: 27660328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.
    Spanagel R; Bilbao A
    Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
    Hollister LE; Gillespie H
    Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dark Classics in Chemical Neuroscience: Δ
    Banister SD; Arnold JC; Connor M; Glass M; McGregor IS
    ACS Chem Neurosci; 2019 May; 10(5):2160-2175. PubMed ID: 30689342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subjective and physiological effects after controlled Sativex and oral THC administration.
    Karschner EL; Darwin WD; McMahon RP; Liu F; Wright S; Goodwin RS; Huestis MA
    Clin Pharmacol Ther; 2011 Mar; 89(3):400-7. PubMed ID: 21289620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nabiximols as a substitute for cannabis].
    Dumont GJH
    Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33201625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative Medicine: Cannabis and Cannabis-Related Drugs.
    Moss DA; Hawks MK; Snyder MJ; Crawford PF
    FP Essent; 2021 Jun; 505():28-34. PubMed ID: 34128629
    [No Abstract]   [Full Text] [Related]  

  • 35. Cannabis and cannabinoids.
    Med Lett Drugs Ther; 2016 Aug; 58(1500):97-8. PubMed ID: 27466748
    [No Abstract]   [Full Text] [Related]  

  • 36. Cannabis in Parkinson's Disease: The Patients' View.
    Yenilmez F; Fründt O; Hidding U; Buhmann C
    J Parkinsons Dis; 2021; 11(1):309-321. PubMed ID: 33216043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
    Parker LA; Kwiatkowska M; Burton P; Mechoulam R
    Psychopharmacology (Berl); 2004 Jan; 171(2):156-61. PubMed ID: 13680081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.
    Arellano AL; Papaseit E; Romaguera A; Torrens M; Farré M
    CNS Neurol Disord Drug Targets; 2017; 16(5):554-566. PubMed ID: 28412920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.
    Inglet S; Winter B; Yost SE; Entringer S; Lian A; Biksacky M; Pitt RD; Mortensen W
    Ann Pharmacother; 2020 Nov; 54(11):1109-1143. PubMed ID: 32483988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.